TGF-beta signalling in colon carcinogenesis

被引:129
作者
Lampropoulos, Pavlos [1 ]
Zizi-Sermpetzoglou, Adamantia [2 ]
Rizos, Spyros [1 ]
Kostakis, Alkiviadis [3 ]
Nikiteas, Nikolaos [3 ]
Papavassiliou, Athanasios G. [4 ]
机构
[1] Tzaneio Gen Hosp, Dept Surg 1, Athens, Greece
[2] Tzaneio Gen Hosp, Dept Pathol, Athens, Greece
[3] Univ Athens, Sch Med, Dept Propaedeut Surg 2, GR-11527 Athens, Greece
[4] Univ Athens, Sch Med, Dept Biol Chem, GR-11527 Athens, Greece
关键词
TGF-beta signalling pathway; Colorectal cancer (CRC); Targeted therapy; GROWTH-FACTOR BETA-1; HUMAN COLORECTAL-CANCER; MICROSATELLITE INSTABILITY; SOLUBLE BETAGLYCAN; TUMOR-SUPPRESSOR; LIVER METASTASIS; GENE-MUTATIONS; IMMUNE CELLS; II RECEPTOR; SMAD4;
D O I
10.1016/j.canlet.2011.09.041
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Colorectal cancer remains the most common cancer and the second leading cause of cancer mortality in Europe. There are a number of pathways that have been implicated in colorectal carcinogenesis, including TGF-beta (TGF-beta)/Smad signalling pathway. The TGF-beta pathway is involved in several biological processes, including cell proliferation, differentiation, migration and apoptosis. Here we review the role of TGF-beta signalling cascade in colorectal carcinogenesis and provide some new molecular insights that may aid efforts towards targeted antitumor therapies. (C) 2011 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:1 / 7
页数:7
相关论文
共 67 条
[1]   TGF-β signaling in cancer -: a double-edged sword [J].
Akhurst, RJ ;
Derynck, R .
TRENDS IN CELL BIOLOGY, 2001, 11 (11) :S44-S51
[2]   Genomic structure of the human Smad3 gene and its infrequent alterations in colorectal cancers [J].
Arai, T ;
Akiyama, Y ;
Okabe, S ;
Ando, M ;
Endo, M ;
Yuasa, Y .
CANCER LETTERS, 1998, 122 (1-2) :157-163
[3]   ANTI-TRANSFORMING GROWTH-FACTOR (TGF)-BETA ANTIBODIES INHIBIT BREAST-CANCER CELL TUMORIGENICITY AND INCREASE MOUSE SPLEEN NATURAL-KILLER-CELL ACTIVITY - IMPLICATIONS FOR A POSSIBLE ROLE OF TUMOR-CELL HOST TGF-BETA INTERACTIONS IN HUMAN BREAST-CANCER PROGRESSION [J].
ARTEAGA, CL ;
HURD, SD ;
WINNIER, AR ;
JOHNSON, MD ;
FENDLY, BM ;
FORBES, JT .
JOURNAL OF CLINICAL INVESTIGATION, 1993, 92 (06) :2569-2576
[4]   Systemic administration of a soluble betaglycan suppresses tumor growth, angiogenesis, and matrix metalloproteinase-9 expression in a human xenograft model of prostate cancer [J].
Bandyopadhyay, A ;
Wang, L ;
Lóepz-Casillas, F ;
Mendoza, V ;
Yeh, IT ;
Sun, LZ .
PROSTATE, 2005, 63 (01) :81-90
[5]   Extracellular domain of TGFβ type III receptor inhibits angiogenesis and tumor growth in human cancer cells [J].
Bandyopadhyay, A ;
Zhu, Y ;
Malik, SN ;
Kreisberg, J ;
Brattain, MG ;
Sprague, EA ;
Luo, J ;
López-Casillas, F ;
Sun, LZ .
ONCOGENE, 2002, 21 (22) :3541-3551
[6]   Mutational inactivation of TGFBR2 in Microsatellite unstable colon cancer arises from the cooperation of genomic instability and the clonal outgrowth of transforming growth factor β resistant cells [J].
Biswas, Swati ;
Trobridge, Patricia ;
Romero-Gallo, Judith ;
Billheimer, Dean ;
Myeroffs, Lois L. ;
Willson, James K. V. ;
Markowitz, Sanford D. ;
Grady, William M. .
GENES CHROMOSOMES & CANCER, 2008, 47 (02) :95-106
[7]   Smads:: Transcriptional activators of TGF-β responses [J].
Derynck, R ;
Zhang, Y ;
Feng, XH .
CELL, 1998, 95 (06) :737-740
[8]  
DERYNCK R, 1997, BIOCHIM BIOPHYS ACTA, V1333, pF150
[9]   Prognostic role of CD10+ myeloid cells in association with tumor budding at the invasion front of colorectal cancer [J].
Do Trong Khanh ;
Mekata, Eiji ;
Mukaisho, Ken-ichi ;
Sugihara, Hiroyuki ;
Shimizu, Tomoharu ;
Shiomi, Hisanori ;
Murata, Satoshi ;
Naka, Shigeyuki ;
Yamamoto, Hiroshi ;
Endo, Yoshihiro ;
Tani, Tohru .
CANCER SCIENCE, 2011, 102 (09) :1724-1733
[10]   MADR2 maps to 18q21 and encodes a TGF beta-regulated MAD-related protein that is functionally mutated in colorectal carcinoma [J].
Eppert, K ;
Scherer, SW ;
Ozcelik, H ;
Pirone, R ;
Hoodless, P ;
Kim, H ;
Tsui, LC ;
Bapat, B ;
Gallinger, S ;
Andrulis, IL ;
Thomsen, GH ;
Wrana, JL ;
Attisano, L .
CELL, 1996, 86 (04) :543-552